RITEDOSE CORP FDA Approval ANDA 214531

ANDA 214531

RITEDOSE CORP

FDA Drug Application

Application #214531

Application Sponsors

ANDA 214531RITEDOSE CORP

Marketing Status

None (Tentative Approval)001
Prescription002

Application Products

001SOLUTION;INHALATIONEQ 0.021% BASE0ALBUTEROL SULFATEALBUTEROL SULFATE
002SOLUTION;INHALATIONEQ 0.042% BASE0ALBUTEROL SULFATEALBUTEROL SULFATE

FDA Submissions

UNKNOWN; ORIG1TA2021-01-05UNKNOWN

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAN
002PrescriptionAN

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214531
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.